期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
紫草素温度敏感型贴膜的制备与功效评价 被引量:2
1
作者 葛志名 陈晗瑶 +2 位作者 杜欣春 韩蒙蒙 李瑾 《国际药学研究杂志》 CAS 北大核心 2019年第8期614-624,634,共12页
目的选取泊洛沙姆407作为基本骨架型高分子材料制备创面用紫草素温度敏感型贴膜,并对其性质和功效进行初步评价。方法建立黏附力评价模型筛选成膜材料的种类和复配比例;通过比较pH、成膜时间、成膜材料吸收性、撕拉强度、水蒸气透过率... 目的选取泊洛沙姆407作为基本骨架型高分子材料制备创面用紫草素温度敏感型贴膜,并对其性质和功效进行初步评价。方法建立黏附力评价模型筛选成膜材料的种类和复配比例;通过比较pH、成膜时间、成膜材料吸收性、撕拉强度、水蒸气透过率选优处方;通过豚鼠透皮渗透性实验及皮肤滞留实验评价紫草素温敏贴膜于皮肤结构中的累积作用部位;建立豚鼠皮肤创伤模型初步评价伤口愈合效果;并考察温度敏感型贴膜潜在的用药安全性问题。结果温度敏感型贴膜最优处方为:泊洛沙姆407含量10%、聚乙烯醇0588 10%、PVP2%;其可协助紫草素累积滞留于皮肤内部结构中,有效发挥药物局部抗炎抗菌、促进伤口愈合的作用;皮肤愈合过程与皮肤切片HE染色的初步考察也证实,温度敏感型贴膜有助于皮肤对于创口的覆盖及皮肤附属器的修复再生,一定程度上能缩短皮肤伤口的愈合时程,且整个用药周期中紫草素敏感型贴膜并未显示有皮肤刺激性。结论紫草素温度敏感型贴膜可在体表温度触发下迅速成膜,且贴膜各方面性能良好,患者用药方便,顺应性好;对于豚鼠皮肤创口愈合具有积极作用,无刺激性,用药安全性好,具有成为临床促进创面愈合潜在外用制剂的应用前景。 展开更多
关键词 温度敏感型贴膜 泊洛沙姆407 紫草素 伤口愈合 生物黏附力
下载PDF
Relationship between tissue type plasminogen activator and coronary vulnerable plaque in patients with acute coronary syndrome: virtual histological study 被引量:9
2
作者 WANG Hai-bin KANG Wei-qiang +4 位作者 SONG Da-lin WANG Xu REN Guo-rui TENG Jin-long ge zhi-ming 《Chinese Medical Journal》 SCIE CAS CSCD 2008年第6期540-543,共4页
Background The association between vulnerability of plaque assessed with intravascular ultrasound (IVUS) and plasma levels of fibrinolytic biomarkers was determined in patients with acute coronary syndrome (ACS). ... Background The association between vulnerability of plaque assessed with intravascular ultrasound (IVUS) and plasma levels of fibrinolytic biomarkers was determined in patients with acute coronary syndrome (ACS). However, few data are available on the relationship between the levels of tissue type plasminogen activator (t-PA) and virtual histological intravascular ultrasound (VH-IVUS) signs of plaque instability. Methods Eighty-nine patients with ACS were enrolled in the study. Blood was collected to measure t-PA levels by liquid phase bead flow cytometry. Eighty-nine nonbifurcate lesions (identified by coronary angiography and ECG) were investigated using IVUS before catheterization. IVUS radiofrequency data obtained with a 20 MHz catheter were analyzed with IVUS virtual histological software. The areas of plaque and media were calculated and lesions were classified into two groups: VH-IVUS derived thin cap fibroatheroma (VH-TCFA) and non-VH-TCFA plaque. Results Plasma t-PA level in the patients with TCFA was significantly lower than that with non-TCFA ((1489 ± 715) pg/ml vs (2163 ± 1004) pg/ml). Decreased plasma levels of t-PA were associated with plaque vulnerability. Plasma levels of t-PA correlated negatively with plaque plus media and necrotic core in plaque in patients with ACS. Conclusions t-PA is an independent risk factor and a powerful predictor of vulnerable plaques. Decreased levels of t-PA may reflect instability of atherosclerotic plaques and might therefore serve as noninvasive determinants of those at high risk for consequent adverse events. 展开更多
关键词 acute coronary syndrome tissue type plasminogen activator vulnerable plaque diagnostic technique intravascular ultrasound
原文传递
套扎术治疗痔300例临床疗效评价 被引量:1
3
作者 赵红波 杨云 +4 位作者 吴晓晶 葛志明 梁同义 丁波 王宏伟 《中国肛肠病杂志》 2020年第9期22-26,共5页
为评价套扎术治疗痔的临床有效性,将600例内痔或混合痔患者随机分为治疗组和对照组各300例。治疗组采用痔疮套扎治疗,对照组采用外切内扎术治疗。观察两组手术指标、并发症及疗效。结果显示,治疗组手术时间、创面愈合时间、术中出血量... 为评价套扎术治疗痔的临床有效性,将600例内痔或混合痔患者随机分为治疗组和对照组各300例。治疗组采用痔疮套扎治疗,对照组采用外切内扎术治疗。观察两组手术指标、并发症及疗效。结果显示,治疗组手术时间、创面愈合时间、术中出血量和治疗费用等评分均优于对照组(P<0.05),治疗2周后治疗组临床总有效率高于对照组,差异有统计学意义(P<0.05)。治疗组术后创面感染、继发肛裂、尿潴留、肛门水肿等积分及发生率均低于对照组(P<0.05),治疗组术后各时间点肛门疼痛、肛门坠胀及便血积分均优于对照组(P<0.05)。两组除术后8h排便不畅积分差异无统计学意义(P>0.05),其余时间点治疗组症状积分均低于对照组,差异有统计学意义(P<0.05)。结果表明,痔套扎术治疗内痔能有效缓解临床症状,减少并发症发生,提高患者术后生存质量,是一种安全、经济、有效的微创疗法,适宜基层推广应用。 展开更多
关键词 内痔 套扎术 疗效
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部